MEDS · DataMEDS AI, Inc.

On May 1, 2026, Wellgistics, LLC, a wholly owned subsidiary of Wellgistics Health, Inc., entered into a Forbearance Agreement with Marco Capital, Inc. to address approximately $1.77 million in outstanding obligations under an existing Loan and Security Agreement. The agreement provides a temporary forbearance period through June 15, 2026, during which MCI will not exercise its rights and remedies under the loan documents. In exchange, Wellgistics agreed to make bi-weekly payments of $50,000 starting May 5, 2026, with interest accruing at Term SOFR plus 11.5% per annum. Additionally, a portion of net proceeds from any future financing transactions by the company or its affiliates during the forbearance period may be required to be applied toward repayment, with escalating percentages based on the amount raised. The parent company and certain management guarantors reaffirmed their guarantees and waived defenses. This agreement provides short-term liquidity relief but imposes significant repayment obligations and restricts the company's financial flexibility. Investors should monitor the company's ability to meet the payment schedule and the outcome of any potential financing transactions.